Intrinsiqs

Is The Pennant Group, Inc. overvalued?

The Pennant Group, Inc. (PNTG) looks undervalued — trading about 25% below its fair value.

Undervalued
Current price $36.07 Fair value $45.10
Price
$36.07
Fair value
$45.10
Current P/E
29.3
Normal P/E
36.7
Market cap
$1.27B
Dividend yield
0.0%
Return on equity
10.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PNTG's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.